Medical management of common peripheral vestibular diseases

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 18, Issue 5, 2010, Pages 407-412

  Hamid, Mohamed ^a  

^a Cleveland Hearing and Balance Center   (United States)

Author keywords

benign paroxysmal positional vertigo; electronystagmography; Meniere's disease; neurotological examination; vertigo; vestibular neuritis; vestibular rehabilitation

Indexed keywords

ANTIEMETIC AGENT; BENZODIAZEPINE; BETAHISTINE; GENTAMICIN; METHOTREXATE; POTASSIUM SPARING DIURETIC AGENT; STEROID;

BALANCE DISORDER; BENIGN PAROXYSMAL POSITIONAL VERTIGO; CRANIAL NERVE; DIZZINESS; EAR TUMOR; ELECTROCOCHLEOGRAPHY; ELECTRONYSTAGMOGRAPHY; ENDOLYMPH; ENT EXAMINATION; EYE MOVEMENT; GAIT; GAIT DISORDER; HEAD MOVEMENT; HEARING LOSS; HEARING TEST; HUMAN; HYPERVENTILATION SYNDROME; INNER EAR DISEASE; LABORATORY TEST; MENIERE DISEASE; MOLECULAR BIOLOGY; NYSTAGMOGRAPHY; OTOACOUSTIC EMISSION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SEMICIRCULAR CANAL; SINGLE DRUG DOSE; SODIUM RESTRICTION; STABILOGRAPHY; STRIA VASCULARIS; VERTIGO; VESTIBULAR EVOKED MYOGENIC POTENTIAL; VESTIBULAR NERVE; VESTIBULAR NEURONITIS; VESTIBULAR TEST; VESTIBULOOCULAR REFLEX;

HUMANS; MENIERE DISEASE; VERTIGO; VESTIBULAR DISEASES; VESTIBULAR NEURONITIS;

EID: 77957764894     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e32833e587a     Document Type: Review

References (57)

1. Hamid M, Sismanis A. Clinical approach to patients with auditory and vestibular disorders. In: Hamid M, Sismanis A, editors. Medical otology and neurotology. A clinical guide to auditory and vestibular disorders. New York: Thieme; 2006. pp. 43-63.
2. Newman-Toker DE, Cannon LM, Stofferahn ME, et al. Imprecision in patient reports of dizziness symptom quality: a cross-sectional study conducted in an acute care setting. Mayo Clin Proc 2007; 82:1329-1340.
3. Kerber KA. Vertigo presentations in the emergency department. Semin Neurol 2009; 29:482-490.
4. Stephens D, Pyykko I, Varpa K, et al. Self-reported effects of Meniere's disease on the individual's life: a qualitative analysis. Otol Neurotol 2010; 31:335-338.
5. Hamid MA, Sismanis A. Clinical anatomy and physiology of the auditory and vestibular systems. In: Hamid M, Sismanis A, editors. Medical otology and neurotology. A clinical guide to auditory and vestibular disorders. New York: Thieme; 2006. pp. 1-10.
6. Choi KD, Kim JS, Kim HJ, et al. Hyperventilation-induced nystagmus in peripheral vestibulopathy and cerebellopontine angle tumor. Neurology 2007; 69:1050-1059.
7. Hamid MA, Sismanis A. Peripheral auditory and vestibular disorders. In: Hamid M, Sismanis A, editors. Medical otology and neurotology. A clinical guide to auditory and vestibular disorders. New York: Thieme; 2006. pp. 64-84.
8. Hamid MA. Clinical and laboratorytestsofvestibularand balancefunction. In: Hughes G, Pensak M, editors. Textbookof clinical otology. New York:Thieme; 1996.
9. Hamid MA. Criteria for diagnosing bilateral reduced vestibular function. In: Graham MD, Kemink JL, editors. Thevestibularsystem: neurophysiologic and clinical research. New York: Raven Press; 1987. pp. 115-118.
10. Rosengren SM, Welgampola MS, Colebatch JG. Vestibularevoked myogenic potentials: past, present and future. Clin Neurophysiol 2010; 121:636-651.
11. Pfammatter A, Darrouzet V, Gartner M, et al. A superior semicircular canal dehiscence syndrome multicenter study: is there an association between size and symptoms? Otol Neurotol 2010; 31:447-454.
12. Welgampola MS, Myrie OA, Minor LB, Carey JP. Vestibular-evoked myogenic potential thresholds normalize on plugging superior canal dehiscence. Neurology 2008; 70:464-472.
13. Zhou G, Gopen Q, Poe DS. Clinical and diagnostic characterization of canal dehiscence syndrome: a great otologic mimicker. Otol Neurotol 2007; 28:920-926.
14. Katayama N, Yamamoto M, Teranishi M, et al. Relationship between endolymphatic hydrops and vestibular-evoked myogenic potential. Acta Otolaryngol 2010; 130:917-923.
15. Neuhauser H, Lempert T. Vestibular migraine. Neurol Clin 2009; 27:379-391.
16. Gianoli G, Goebel J, Mowry S, Poomipannit P. Anatomic differences in the lateral vestibular nerve channels and their implications in vestibular neuritis. Otol Neurotol 2005; 26:489-494.
17. Kim HA, Hong JH, Lee H, et al. Otolith dysfunction in vestibular neuritis: recovery pattern and a predictor of symptom recovery. Neurology 2008; 70:449-453.
18. Gacek RR. Evidence for a viral neuropathy in recurrent vertigo. ORL J Otorhinolaryngol Relat Spec 2008; 70:6-14.
19. Goudakos JK, Markou KD, Franco-Vidal V, et al. Corticosteroids in the treatment of vestibular neuritis: a systematic review and meta-analysis. Otol Neurotol 2010; 31:183-189.
20. Strupp M, Brandt T. Vestibular neuritis. Semin Neurol 2009; 29:509-519.
21. van Leeuwen RB, Bruintjes TD. Recurrent vestibulopathy: natural course and prognostic factors. J Laryngol Otol 2010; 124:19-22.
22. Kattah JC, Talkad AV, Wang DZ, et al. HINTS todiagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke 2009; 40: 3504-3510.
23. Hamid MA. Meniere's disease. Pract Neurol 2009; 9:157-162.
24. Gacek RR. Meniere's disease is a viral neuropathy. ORL J Otorhinolaryngol Relat Spec 2009; 71:78-86.
25. Kariya S, Cureoglu S, Fukushima H, et al. Vascular findings in the stria vascularis of patients with unilateral or bilateral Meniere's disease: a histo-pathologic temporal bone study. Otol Neurotol 2009; 30:1006-1012.
26. Trune DR, Kempton JB. Blocking the glucocorticoid receptor with RU-486 does not prevent glucocorticoid control of autoimmune mouse hearing loss. Audiology & Neurotology 2009; 14:423-431.
27. Hamid M, Trune D. Issues, indications, and controversies regarding intratympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg 2008; 16:434-440.
28. Hirt B, Penkova ZH, Eckhard A, et al. The subcellular distribution of aquaporin 5 in the cochlea reveals a water shunt at the perilymph-endolymph barrier. Neuroscience 2010; 168:957-970.
29. Taguchi D, Kakigi A, Takeda T, et al. Diagnostic value of plasma antidiuretic hormone, electrocochleography, and glycerol test in patients with endolym-phatic hydrops. ORL J Otorhinolaryngol Relat Spec 2010; 71:26-29.
30. Nguyen LT, Harris JP, Nguyen QT. Clinical utility of electrocochleography in the diagnosis and management of Meniere's disease: AOS and ANS mem-bership survey data. Otol Neurotol 2010; 31:455-459.
31. Gibson WP. A comparison of two methods of using transtympanic electro-cochleography for the diagnosis of Meniere's disease: click summating potential/action potential ratio measurements and tone burst summating potential measurements. Acta Otolaryngol Suppl 2009; (560):38-42.
32. Baier B, Dieterich M. Vestibular-evoked myogenic potentials in 'vestibular migraine' and Meniere's disease: a sign of an electrophysiological link? Ann N Y Acad Sci 2009; 1164:324-327.
33. Magliulo G, Parrotto D, Gagliardi S, et al. Vestibular evoked periocular potentialsin Meniere'sdiseaseafterglyceroltesting. Ann Otol Rhinol Laryngol 2008; 117:800-804.
34. Kim-Lee Y, Ahn JH, Kim YK, Yoon TH. Tone burstvestibularevoked myogenic potentials: diagnostic criteria in patients with Meniere's disease. Acta Otolaryngol 2008; 1-5.
35. Tanaka H, Tanigawa T, Suzuki M, et al. Effects of MRI contrast agents (omniscan) on vestibular end organs. Acta Otolaryngol 2010; 130:17-24.
36. Kawai H, Naganawa S, Ishihara S, et al. MR imaging ofthecochlear modiolus after intratympanic administration of Gd-DTPA. Magn Reson Med Sci 2010; 9:23-29.
37. Marshall AF, Jewells VL, Kranz P, et al. Magnetic resonance imaging of guinea pig cochlea aftervasopressin-induced orsurgically induced endolymphatic hydrops. Otolaryngol Head Neck Surg 2010; 142:260-265.
38. Brandt T, Zwergal A, Strupp M. Medical treatment of vestibular disorders. Expert Opin Pharmacother 2009; 10:1537-1548.
39. Mira E. Improving the quality of life in patients with vestibular disorders: the role of medical treatments and physical rehabilitation. Int J Clin Pract 2008; 62:109-114.
40. Lacour M, van de Heyning PH, Novotny M, Tighilet B. Betahistine in the treatment of Meniere'sdisease. Neuropsychiatr Dis Treat 2007; 3:441-453.
41. Bodmer D, Morong S, Stewart C, et al. Long-term vertigo control in patients after intratympanic gentamicin instillation for Meniere's disease. Otol Neurotol 2007; 28:1140-1144.
42. Chung WH, Chung KW, Kim JH, et al. Effects of a single intratympanic gentamicin injection on Meniere's disease. Acta Otolaryngol Suppl 2007; (558):61-66.
43. Nedzelski JM, Bryce GE, Pfleiderer AG. Treatment of Meniere's disease with topical gentamicin: a preliminary report. J Otolaryngol 1992; 21:95-101.
44. Kim SH, Kim KX, Raveendran NN, et al. Regulation of ENa C-mediated sodium transport by glucocorticoids in Reissner's membrane epithelium. Am J Physiol Cell Physiol 2009; 296:C544-C557.
45. Pondugula SR, Raveendran NN, Ergonul Z, et al. Glucocorticoid regulation of genes in the amiloride-sensitive sodium transport pathway by semicircular canal duct epithelium of neonatal rat. Physiol Genomics 2006; 24:114-123.
46. Herraiz C, Plaza G, Aparicio JM, et al. Transtympanic steroids for Meniere's disease. Otol Neurotol 2010; 31:162-167.
47. Garduno-Anaya MA, Couthino DT, Hinojosa-Gonzalez R, et al. Dexametha-sone inner ear perfusion by intratympanic injection in unilateral Meniere's disease: a two-year prospective, placebo-controlled, double-blind, rando-mizedtrial. Otolaryngol Head Neck Surg 2005; 133:285-294.
48. Selivanova OA, Gouveris H, Victor A, et al. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Meniere's-associated sudden sensorineural hearing loss. Otol Neurotol 2005; 26:890-895.
49. Lu Y, Ren J, Wu W, et al. Intratympanic dexamethasone injections for intractable Meniere's disease. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2004; 18:385-387.
50. Hu A, Parnes LS. Intratympanic steroids for inner ear disorders: a review. Audiol Neurootol 2009; 14:373-382.
51. Boleas-Aguirre MS, Lin FR, Della Santina CC, et al. Longitudinal results with intratympanic dexamethasone in the treatment of Meniere's disease. Otol Neurotol 2008; 29:33-38.
52. Stahle J, Friberg U, Svedberg A. Long-term progression of Meniere's disease. Acta Otolaryngol Suppl 1991; 485:78-83.
53. Semont A, Freyss G, Vitte E. Curing the BPPV with a liberatory maneuver. Adv Otorhinolaryngol 1988; 42:290-293.
54. Epley JM. The canalith repositioning procedure: for treatment of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 1992; 107: 399-404.
55. Lempert T. Horizontal benign positional vertigo. Neurology 1994; 44:2213-2214.
56. Hamid MA. The maneuvers for BPPV. Oper Tech Otolaryngol Head Neck Surg 2001; 12:148-150.
57. Hamid MA, Samy HM. Vestibular and balance rehabilitation. In: Hamid MA, Sismanis A, editors. Medical otology and neurotology. A clinical guide to auditory and vestibular disorders. New York: Thieme; 2006. pp. 94-101.